Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Rituximab plus intravenous bolus chemotherapy is a standard treatment for immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL). Some studies have suggested that rituximab is associated with excessive toxicity in HIVassociated NHL, and that infusional chemotherapy may be more effective. We...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Sparano, Joseph A., Lee, Jeannette Y., Kaplan, Lawrence D., Levine, Alexandra M., Ramos, Juan Carlos, Ambinder, Richard F., Wachsman, William, Aboulafia, David, Noy, Ariela, Henry, David H., Von Roenn, Jamie, Dezube, Bruce J., Remick, Scot C., Shah, Manisha H., Leichman, Lawrence, Ratner, Lee, Cesarman, Ethel, Chadburn, Amy, Mitsuyasu, Ronald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2010
Aiheet:
Clinical Trials and Observations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858478/
https://ncbi.nlm.nih.gov/pubmed/20023215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-231613
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia